In addition it addresses the FDA’s communications Using the applicant, the retention of records that help the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may possibly transfer possession of the SE report to a fresh applicant and Digital submission in the SE report and amendmen